🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Alcohol-related liver cancer (ALD-HCC) accounts for 30% of liver cancer cases worldwide. Even one drink a day can increase cancer risk. #GENIALProject is leading a cutting-edge initiative to improve early detection of the disease. #LiverCancer #ALDHCC #CancerAwareness

🌍 October is Liver Cancer Awareness Month!🎗️ 🚨 Did you know? About 1 in 10 people suffering from #alcohol use disorder develop cirrhosis, and a worrying 4% of those with #cirrhosis will go on to develop #livercancer. The statistics are alarming, but there is hope! At

Excited to have the Champalimaud Foundation as a GENIAL partner! They’re leading functional validation of hepatic metabolism and gene-environment interactions in preclinical models. Discover more about them: fchampalimaud.org🔍 #GENIALProject #ChampalimaudFoundation

Exploring the gene-environment interaction in alcohol-related liver cancer through the #GENIALProject. Together, we're identifying risks, studying molecular interactions, and driving prevention. 🔬🧬 Follow us for regular updates! 🌍 #AI #LiverCancer #MedicalResearch

📢 Start your career at the Home of Hepatology & join thousands of Young Investigators at #EASLCongress 2025! Here's why 👇 Register now: easlcongress.eu #LiverTwitter

Happy to share our review on steatotic liver disease, published today in The Lancet 🔗thelancet.com/journals/lance… Sven Francque Aleksander Krag & Tsochatzis :-) #livertwitter #MedTwitter The Lancet Gastroenterology & Hepatology

Thrilled to have ULB leading project coordination for #GENIALProject and driving the discovery of novel genetic variants and their roles in ALD-HCC development. Their leadership is crucial to our success! Explore more about ULB: ulb.be 🧬🔍 #Genetics #ULB

Excited to share that WP2 is diving into how genetic variations from WP1 interact with environmental factors to better understand and prevent alcohol-related liver cancer (ALD-HCC). Stay tuned for insights and exciting updates on key milestones!🧬#LiverCancer #Genetics

Delighted to have Université Sorbonne Paris-Nord on board with GENIAL! They’re evaluating how environmental risk factors like diet and physical activity impact HCC in ALD and NAFLD cirrhotic patients. Discover their work: univ-spn.fr #GENIALProject #UniversitéSorbonne

On 9th May I will take over as the 1st female Secretary General EASLnews. I am looking for a partner to join me on my leadership journey and join our global hepatology platform🌎 E - Education A - Advocacy S - Science L - Leadership DM or 📞 for an informal chat. #livertwitter

WP4 is all about establishing strong communication strategies for the GENIAL project. We're focused on keeping clinicians, industry pros, scientists, and regulators well-informed and trained. Stay tuned for updates! 🌐📣 #GENIALProject #ScienceCommunication

Excited to have l'Assistance Publique – Hôpitaux de Paris (AP-HP) as a GENIAL partner! They’ll be reviewing histological slides stratified by genotypes to advance our research. Learn more about their role: aphp.fr 🧬🔬 #GENIALProject #MedicalResearch #APHP

Conclusions of a statement of ALD EXPERTS on MetALD: 🔸"Met" should include >1 risk factor: alcohol itself favors metabolic syndrome. 🔸Alcohol thresholds need prospective studies including biomarkers. 🔸Trials testing therapies for MetALD are needed. t.ly/L2JWE

Honoured to speak about #MetALD at the Belgian 🇧🇪 #BASL hepatology meeting - Finally a name - been under our nose all the time! - lets break down silos between Alcohol and CMRF focus- the answer is the holistic view 👉#EASLCongress abstract deadline Dec 3!!

By analyzing sociodemographic and socioeconomic factors, #GENIALProject shows our dedication in understanding how lifestyle habits can impact on ALD-HCC. Follow us for regular updates on our findings!🌍📊 #HealthEconomics #SocialSciences

EASLnews Governing Board meeting - working for the community❤️ 👉SLD and LCS summits 👉EASL schools / what and where? 👉EiC Journal of Hepatology JHEP Reports new initiatives🤩 👉 X vs bluesky ? 👉AI Task Force 👉#EASLCongress 2025 Amsterdam 👉Register grants 👉Global collaboration

Eric Trepo delivers an excellent talk on the role of genetics on SLD EASLnews Aleksander Krag

Few can explain genetics like Eric Trépo 🤩 and put into perspective and clinical context!

Genetics can provide a pathway for therapeutic development, with nucleotide-based therapies targeting key genes showing promise. While genetics enhances understanding of SLD, robust evidence and focus on non-genetic factors are also crucial for advancing patient care and

Rui Castro EASLnews Tom Marjot Pedro Rodrigues Marta Alonso Peña, PhD Carolin V. Schneider, MD @a_zanetto Great interest in the work by young investigators – we had to stand close together as 12% of all attendees at the SLD Summit joined the YI poster tour Harry Pustjens @van Kleef @Dallio Ciro Celsa André Cardador Constanze Höbinger